Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
Location contact
Asha Ganesan
CONTACT
Yhenneko Taylor, PhD
CONTACT
Yhenneko Taylor, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06527794
This study will compare two approaches for managing hypertension in Black patients with uncontrolled blood pressure (BP). One approach will include home BP telemonitoring supported by a pharmacist and a community health worker. The other approach will include usual clinic-based care along with a home BP monitor and routine care.
Interested in participating?
Request Info21 year–85 year
All sexes
Interventional
Not applicable
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
Asha Ganesan
CONTACT
Yhenneko Taylor, PhD
CONTACT
Yhenneko Taylor, PhD
PRINCIPAL_INVESTIGATOR
This study is a pragmatic effectiveness-implementation hybrid type 2 trial with two study arms. One arm will include home BP telemonitoring supported by a pharmacist and a community health worker providing centralized self-management support. The other arm will include enhanced usual clinic-based care with a home BP monitor and routine care from providers trained on evidence-based guidelines.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Home blood pressure telemonitoring with remote medication management by a centralized multidisciplinary team led by a pharmacist; and social support, lifestyle education and connection to community resources to address social needs, provided by a community health worker who is embedded with the centralized team and is tightly connected to community resources and partners
All participating sites will receive training on appropriate blood pressure measurement and education on guideline-based hypertension therapy. Additionally, participants in usual care will receive a standardized packet with evidence-based hypertension education material and a blood pressure monitor to complete blood pressure measurements at home.
Time frame: Month 12
Percent of patients achieving BP control (i.e., SBP<130mmHg)
Time frame: Baseline
Percent of patients achieving BP control (i.e., SBP<130mmHg)
Time frame: Month 6
Percent of patients achieving BP control (i.e., SBP<130mmHg)
Time frame: Month 18
Percent of patients achieving BP control (i.e., SBP<130mmHg)
Time frame: Baseline
Mean SBP (mmHg)
Time frame: Month 6
Mean SBP (mmHg)
Time frame: Month 12
Mean SBP (mmHg)
Time frame: Month 18
Mean SBP (mmHg)
Time frame: Baseline
The hypertension self-care profile score encompassed self-care behaviors crucial to control blood pressure - Includes 3 scales (Behavior, Motivation, Self-efficacy) 20 items each that can be used together or independently. The Behavior scale assesses participant's self-care behaviors on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care behavior. The Motivation scale assesses participant's self-care motivation on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care motivation. The Self-efficacy scale assesses participant's self-care efficacy on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-efficacy. Higher scores indicate better self care behaviors - range from 60-240.
Time frame: Month 12
The hypertension self-care profile score encompassed self-care behaviors crucial to control blood pressure - Includes 3 scales (Behavior, Motivation, Self-efficacy) 20 items each that can be used together or independently. The Behavior scale assesses participant's self-care behaviors on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care behavior. The Motivation scale assesses participant's self-care motivation on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-care motivation. The Self-efficacy scale assesses participant's self-care efficacy on a 4-point Likert scale. Mean scores range from 1-4 with higher scores indicating higher levels of self-efficacy. Higher scores indicate better self care behaviors - range from 60-240.
Time frame: Baseline
Hill-Bone medication adherence scale survey - 14-item Hill-Bone Compliance Scale uses a 4-point Likert scale. Score range from 14-56. Higher scores indicates poorer adherence.
Time frame: Month 12
Hill-Bone medication adherence scale survey - 14-item Hill-Bone Compliance Scale uses a 4-point Likert scale. Score range from 14-56. Higher scores indicates poorer adherence.
Time frame: Baseline
The Patient assessment of chronic illness care (PACIC) survey assess implementation of the chronic care model from the patient perspective. The PACIC includes five subscales addressing specific domains: (1) patient activation; (2) delivery system design/decision support; (3) goal setting/tailoring; (4) problem solving/contextual counselling; and (5) follow-up/coordination. Patients rated care received from their healthcare team (e.g., physicians, nurses, physiotherapists, occupational therapists, social workers) during the past 6-months using a 5-point Likert scale (1 = 'never' to 5 = 'always'). Total and subscale scores (i.e., summed items completed within that scale) are averaged across items.
Time frame: Month 12
The Patient assessment of chronic illness care (PACIC) survey assess implementation of the chronic care model from the patient perspective. The PACIC includes five subscales addressing specific domains: (1) patient activation; (2) delivery system design/decision support; (3) goal setting/tailoring; (4) problem solving/contextual counselling; and (5) follow-up/coordination. Patients rated care received from their healthcare team (e.g., physicians, nurses, physiotherapists, occupational therapists, social workers) during the past 6-months using a 5-point Likert scale (1 = 'never' to 5 = 'always'). Total and subscale scores (i.e., summed items completed within that scale) are averaged across items.
Time frame: Baseline
The SF-36 Total/Global/Overall Score, a global measure of health-related quality of life - scores range from 0-100 with higher scores denoting better quality of life
Time frame: Month 12
The SF-36 Total/Global/Overall Score, a global measure of health-related quality of life - scores range from 0-100 with higher scores denoting better quality of life
Time frame: Baseline
Total days spent in an emergency department, inpatient hospital, or observation unit; number of physician office visits.
Time frame: Month 12
Total days spent in an emergency department, inpatient hospital, or observation unit; number of physician office visits.
Time frame: Month 24
Total days spent in an emergency department, inpatient hospital, or observation unit; number of physician office visits.
Time frame: Month 12
The therapeutic intensity score is a number that reflects the number of medications and the percent of maximal dose of each medication. Numeric range 0-5.
Contact information is provided by the study sponsor or research team.
Asha Ganesan
CONTACT
Yhenneko J. Taylor, PhD
CONTACT
Wake Forest University Health Sciences
Other
Remote Hypertension Tracking, Help, and Management to Reduce Disparities in Black Patients
Acronym: RHYTHM-B
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07142356
Cardiovascular Diseases, Heart Murmurs
Tucson, Arizona, United States
View Trial DetailsNCT07654140
Cardiovascular Diseases, Hypertension
Beijing, Beijing Municipality, China
View Trial DetailsNCT06610448
Cardiovascular Diseases, Controlled Hypertension
Boston, Massachusetts, United States
View Trial DetailsNCT07031739
Cardiovascular Diseases, Hypertension
Winston-Salem, North Carolina, United States
View Trial Details